Literature DB >> 23897082

Genetics: APOBEC-a double-edged sword.

Mina Razzak.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23897082     DOI： 10.1038/nrclinonc.2013.138

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

2.  Evidence for APOBEC3B mutagenesis in multiple human cancers.

Authors:  Michael B Burns; Nuri A Temiz; Reuben S Harris
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330
  2 in total
  1 in total

1.  SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer.

Authors:  Maria Skydt Lindgren; Philippe Lamy; Sia Viborg Lindskrog; Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Benedicte Parm Ulhøi; Jørgen Bjerggaard Jensen; Lars Dyrskjøt
Journal:  Eur Urol Open Sci       Date:  2021-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.